1

Substance Use and Recidivism Outcomes for Prison-Based Drug and Alcohol Interventions

Name

University

Course

Professor

Date
 2

Substance Use and Recidivism Outcomes for Prison-Based Drug and Alcohol Interventions

Abstract

This paper conducted a systematic review and a subsequent thematic analysis of substance use

and recidivism outcomes resulting from prison-biased interventions. Public health, psychology

academic, and criminology databases were searched to identify studies that touched on the topic.

Forward and backward criteria, as well as a host of other criteria, such as the language of

publication, the year, and the study population of the materials, were used to determine exclusion

or inclusion into the study. The results of the thematic analysis of the selected document

suggested that the use of opioid replacement therapize was essential in the reduction of substance

use, recidivism, risky behavior, and criminality among incarcerated patients and those released

from prison. Furthermore, this strategy improved health outcomes among the study population

while ensuring treatment retention after releasing from incarceration. The results of this study

thus provide evidence for policymakers to ensure the implementation of the best practical

strategy to ensure positive outcomes of the interventions.

 3

Introduction

Drug abuse and addiction among the offending population pose a substantial risk to the

justice system and public health. Evidence indicates a compelling relationship between criminal

behaviors and drug and substance abuse. According to de Andrade et al. (2018), drug abusers are

eight times more likely to participate in criminal behavior compared to non-drug users. As such,

more incarcerated persons have been diagnosed with substance dependence. For example, de

Andrade et al. (2018) research states that more than 65 percent of the American incarcerated

population has been found to suffer from substance dependence. The prison population in

America is thus seven times more likely to contract substance abuse disorder than the general

population.

When these persons are released from prison, many resorts to returning to their previous

risky drug and alcohol abuse (de Andrade et al., 2018). This dangerous drug use after one is

released from prison usually increases the risk of nonfatal and fatal overdose and the probability

of contracting infectious diseases such as HIV (Farahmad et al., 2017). These ex-convicts also

find themselves at an increased probability and re-incarceration (Farahmad et al., 2017). This

stems from the fact that their relapse will trigger engagement in criminal activities. It is also

noticeable that the risk of recidivism among the released prisoners is increased by the use of

drugs such as opioids and cannabis and engagement in risky patterns such as the usage of

injection drugs (de Andrade et al., 2018).

Several initiatives have been introduced to ensure that the incarcerated population is

offered effective treatment and that they continue their treatment once out of prison. Opioid

maintenance programs have been enrolled in the justice facilities to reduce drug injection and

associated harms such as spreading diseases through blood. The justice system has also adopted
 4

the trial of psychological treatment options such as motivational interviews. These strategies

enhance readiness for change and motivation among the prisoners. The main challenge is that

there is less clear evidence relating to the effectiveness of the treatment approaches in prison in

reducing drug use disorder and recidivism. This presents a difficulty in comparing the treatment

options and assessing the impact of these treatment methods on recidivism and substance use

outcomes. This study thus aims to conduct a systematic literature review of publications that

conduct an evaluation of recidivism and substance abuse outcomes of incarceration-based drug

and alcohol interventions. Based on the review findings, we will thus be able to offer an update

on the prison-based drug and alcohol interventions and determine the effectiveness of such

methods.

The outcomes of this paper will be vital to social work since it will aid in highlighting the

essential method for reducing substance abuse disorder and recidivism. This topic forms a

critical aspect of social work as social workers participate in the fight against drug and alcohol

abuse and recidivism on numerous fronts. One of such duties is participating in academic

research on substance abuse and developing treatment strategies and empirically-validated

interventions (Miller, 2022). These duties are sometimes conducted in collaboration with several

government agencies, including National Institute on Drug Abuse. Social workers also contribute

to this field by working in schools, mental health clinics, hospitals, and private practice. Their

primary duties in these institutions involve conducting a comprehensive client assessment and

recording any account of potential alcohol and substance abuse (Miller, 2022). This is done even

if the client opts not to self-report such accounts. The social worker is then tasked with

acknowledging any warning signs and suggesting a course of treatment. The social workers will
 5

thus be in a better position to suggest the most effective treatment strategy for the incarcerated

population by using the results of this study (Miller, 2022).

The results of this study will also be vital in the social work intervention for substance

abuse counseling in a prison setting. The social worker can employ the findings to offer essential

assessment and identification services while in direct work with members of the population

undergoing drug abuse disorder (Miller, 2022). This will enable the social worker to offer the

affected person perfect individual or group counseling.

Key Concepts

Therapeutic Communities

These distinct treatment units offer accommodation to prisoners under treatment in

separation from the non-participants. According to Galassi et al. ( 2015), an aggressive and

supportive approach describes these communities accompanied by focusing on underlying

disorders rather than drug abuse and the involvement of the residents. These communities

effectively address the challenges of drug use and recidivism among the population under

incarceration.

Opioid Replacement Therapy

This substitution therapy employs evidence-based interventions for opiate-addicted

persons (Boksán et al., 2022). Under this therapy, illegal opioid use is replaced with an orally

administered opiate that has been medically prescribed. Such medications include methadone

and buprenorphine.

Substance Abuse Disorder

This is a condition that impacts the brain and behavior of an individual and leads them to be

unable to control their use of illegal or legal drugs and medicine (Chandler et al., 2009).
 6

Substance abuse begins with the experimental use of recreational drugs in social situations,

leading to increased drug use. In some cases, substance abuse disorder occurs through taking

prescribed medication or obtaining the drugs from individuals with prescriptions.

Drug and Alcohol Interventions

These approaches promote health and wellness, reduce harm, and improve safety among

drug and alcohol-dependent individuals (de Andrade et al., 2018). Interventions in this context

involve finding the best strategies for aiding incarcerated persons to avert their drug and alcohol

dependencies while continuing their treatment after they have been released into society.

Methodology

Search Strategy

This study searched psychology, public health, criminology, and psychology databases,

including Medline, PsycINFO, and Cumulative Index of Nursing and Allied Health. We also

searched several academic databases such as google scholar, PubMed, JSTOR, and ScienceDirect for

sources that touched on substance use and recidivism outcomes for prison-based drug and alcohol

interventions. This search was tailored to ensure that majority of the sources obtained were those

published from 2005, with few exceptions. This was done due to the shifting dynamics in prison

management, treatment options, and drug use among the incarcerated population. The search string

applied to the population under study and the interventions with no limitation on the study outcome

or design. The study employed two search strings were employed. These were the abstract and the

paper title. In addition, the search was restricted to academic journals published in English, with

reverse and forward snowballing used to locate additional publications. A thematic analysis was then

used to conducted to identify recurrent themes that highlighted the effectiveness of treatment

interventions for drug and alcohol use disorders in prison

Exclusion and Inclusion Criteria

 7

All studies that analyzed the efficiency of alcohol and drug intervention programs initiated or

administered in correctional facilities were included. Several criteria were used to warrant inclusion

in the study. These included: self-identification or classification of the study population engaged in

risky drug abuse behaviors or alcohol and drug users, published in English, recidivism after release

from incarceration, and continued substance use after the intervention. Studies that explored drug

abuse intervention in other settings apart from prison were excluded from the study. Sources were

also excluded from the review if the study population included juveniles.

Methodological Quality Assessment

The quality assessment tool for qualitative studies provided by Effective Health Practice

Project was utilized to assess the methodological quality of the extracted research. This tool's factors

under consideration included inter0reliability, construct validity, and content validity. Six criteria

were employed for the basis of the studies' ratings. These included: the data collection approach,

confounders, design employed for the study, selection bias, blinding, and value. The six criteria were

rated as either weak, moderate, or strong. A study was deemed weak if it had more than 2 weak

ratings, strong if it had no weak ratings, and moderate in the existence of one weak rating. If the

criterion did not conform to the study design, it was issued a rating of not applicable. After the rating,

the next step involved conducting a methodological quality assessment for each assessment, and

discussion was employed to resolve any disparity.

Thematic Analysis

Results

Based on the analysis of the selected studies, three themes were identified that explored

substance use and recidivism outcomes for prison-based drug and alcohol interventions. These

included substance abuse and dependence among prisoner populations, medical assisted and

opioid replacement treatment, and treatment retention. These themes enabled the obtainment of a
 8

complete understanding of the effectiveness of the intervention on alcohol and drug use in

relation to providing aid for dependency disorder and reducing recidivism among those released

from prison.

Substance Abuse and Dependence among Prisoner Populations

The criminal justice system and medical settings have exhibited substance abuse and

offending relationships. In recent times, prospective studies have indicated the rations between

being diagnosed with drug and substance abuse and succeeding violent criminal behavior among

patients discharged into the community and those leaving hospitals. In research from Peters

(2006), correctional institutions have acted as outposts for public health by serving the increasing

number of incarcerated populations who possess specialized healthcare needs, including those

suffering from substance abuse disorder. Peters notes that many of these prisoner population

members had not previously been offered enough substance abuse treatment services. This

means that while in jail, the institutions face an uphill task of addressing both the presence of

chronic conditions such as prolonged dependency and the acute need for detoxification. The

statement of Peters mirrors the findings of Fazel et al. (2006). They state that prions may offer

the only opportunity for the marginalized population to be accorded treatment services

concerning alcohol and drug use disorder.

According to Fazel et al. (2006), the estimation of substance abuse and dependence

among the poisoner population has shown huge disparities. One of the contributors to the

variations in drug and substance abuse prevalence is the cross-sectional nature of the prison

surveys used and the nature of substance availability in those prisons over a given duration.

Other reasons for the disparities include Similar changes in the procedures of the criminal justice

system, including policies affecting the sentencing of individuals with offenses related to drugs
 9

and variations in drug and substance abuse behaviors across countries in society over time (Fazel

et al., 2006). Other causes of disparities were related to the nature of the research with impacting

variables comprising of issues such as self-reported measures and samples selected for the study.

The prevalence figures indicate a higher magnitude of alcohol and substance use

dependencies among the prisoner population compared to those in the general public. Their

comparison of the prevalence figures for the general population in the United States showed a

minor excess alcohol dependency among the prisoner population and excessive double values in

drug abuse (Curtis et al., 2020). These values were reflected in comparison among male

prisoners of the same age. When the female prisoners were analyzed, the results showed a stark

difference between the prevalence of alcohol and drug dependencies among the prisoner

population and the general population. This difference ranged between double and four times

figures in the disparity of alcohol dependence. In contrast, the dependence disparity figures

between the general and prisoner populations stood at a significantly high value of thirteen times

in excess.

The substance abuse dependence figures among the prisoner population thus raise more

significant concerns with a massive disparity between the incarcerated population and the

general population. The figures also indicate high dependence on substance and alcohol use in

the female prisons compared to the male prisons, creating a need for more interventions to be

contributed in the female correction facilities compared to the male ones. Fazel et al. (2006) also

state that substance misuse among the incarcerated population presents a risk factor for suicide

during incarceration and after one is released from prions. As such, there should be treatment

interventions for alcohol and substance abuse disorder as part of the suicide prevention strategy.

It is noted that correctional facilities in numerous countries, such as the United Kingdom, have
 10

introduced staff to help aid prisoners with substance abuse disorders and provide a link between

them and outside organizations and agencies after they are released from incarceration. Despite

this, wide variations exist in the provision of interventions for treatment and protocols based on

the institutions. The specific areas in which these variations thrive include policies for

prescribing maintenance medication and issuing detoxification routines. Alcohol dependency

management in these correctional facilities is usually limited to detoxification while offering

minimal psychological assistance and the provision of aftercare (Hamilton, 2017). In their

findings, Fazel et al. (2006) suggest the existence of a role via prisoner screening on admission

for dependency and substance abuse and for the issuance of appropriate treatment interventions

and facilities both within the prison and after one is released from incarceration through

providing suitable thorough care. Such includes the provision of maintenance prescriptions and

initiating strategies and works to prevent relapse among these prisoners.

Medical Assisted and Opioid Replacement Treatment

Opioid addiction is a relapsing and chronic disorder that has an association with legal

challenges, criminal behavior, unemployment, and the risk of contracting infectious diseases

(Friedmann et al., 2018). There are numerous counts of opioid addiction among the populations

in correctional facilities. The prisoners whose addictions are not subjected to treatment and

interventions while in prison usually relapse once they are released from incarceration. This

poses a risk of contracting serious diseases such as hepatitis C, overdose, and psychological

challenges such as recidivism. Due to this, the food and drug administration agency in the United

States has approved three types of medication for the treatment of opioid usage disorder. These

are naltrexone, methadone, and buprenorphine. Such opioid replacement therapies are associated

with high benefits to the patients, including reducing criminality, reducing deaths related to
 11

opioid usage, and reducing incidences of contracting diseases such as HIV. However, most

incarcerated people who have grown dependent on opioid usage in the United States correctional

facilities are forced to halt their opioid-related therapies upon incarceration.

There is a general understanding that opioid replacement therapies are the most vital

standard for preventing relapse in persons experiencing opioid usage disorder in the prison

environment and the general population. It also reduces the spread of infectious diseases that

accompanies the unlawful usage of opioids. In addition, this intervention is essential in ensuring

the reduction in criminal activities and mortality among opioid-dependent persons (Hedrich et

al., 2012). Public health committees in the international community have approved the opinion of

the eligibility of incarcerated persons to be issued medical care similar to those issued to the

general population. This has seen the introduction of opioid replacement therapies in numerous

countries across the globe, but the United States still lags behind in the introduction of this

initiative. The efforts to ensure the introduction of opioid replacement therapies have been

impacted by security concerns related to opioid replacement therapy diversion overdoes and

logistics challenges such as staff education and storage of the drugs (Hedrich et al., 2012).

Opioid maintenance treatment is also a practical option for the treatment of opioid

dependency. The benefits of applying this method include ensuring treatment retention, reducing

the volume of heroin usage, improving the general health of the patient, and eliminating risk

behaviors. The opioid retention treatment initiative also results in the improvement of criminal

and social justice outcomes. The enhancement of positive outcomes in the treatment of

dependency among opioid-dependent individuals stems from factors such as ensuring treatment

continuity, adequate dosages, and the provision of accompanying psychological assistance. The

use of opioid maintenance treatment is also associated with cost-effectiveness. Despite the
 12

critical role that opioid replacement treatment plays in community-based initiatives, this

intervention is yet to be fully implemented in correctional facilities. However, recent years have

seen more prisons addressing the method, especially in the European Union. According to the

research by Hedrich et al. (2012), opioid maintenance treatment initiative in prison is essential in

ensuring a significant reduction in heroin, syringe sharing, and injection while incarcerated.

However, there must be adequate dose provision. Despite the little impact on non-opioid drugs,

studies have indicated that there is consistency in the results of the reduction of heroin use and

accompanied risk when this method is employed both in the community and in prison (Hedrich

et al., 2012). This consistency is even closer when higher dosages are administered for an

adequate period. This provides evidence that the use of opioid maintenance treatment is an

effective strategy for reducing heroin usage and risk activities in prison settings. According to

research by Larney et al. (2016), there is no clarity as to why several individuals seek opioid

replacement treatment before being released from prison. Some results have pointed toward

patients feeling significant uncertainty toward opioid substitution treatment.

Treatment Retention

Many of the treatment outcomes involving prisoners, including sex offenders, are usually

of voluntary nature (Stöver, 2010). The success of such interventions is usually subject to

individual approaches, including the completion of treatment and volunteering for the treatment.

Those patients who drop out of treatment opt out of treatment before completion and usually

exhibit a higher rate of recidivism than those who complete their treatment. Several factors affect

treatment completion among the incarcerated population. Persons who have not been previously

convicted or committed serious crimes such as sexual victimization have higher chances of

completing their treatments (Toson et al., 2011). Other studies have also indicated that persons
 13

who complete their medication are less likely to have an antisocial personality disorder and

possess substance use diagnoses. A person who completes their substance use medication is also

less likely to have committed violent offenses in the past (Smyth et al., 2018). Prisoners released

from incarceration while on opioid replacement treatment have a higher probability of entering

treatment programs and completing their medication compared to those who leave without being

enrolled in opioid replacement treatment (Soyka et al., 2017). As such, these individuals have a

significantly lower mortality risk, and they pose reduced drug use, less risky behavior, and

reduced criminality. s

Discussion

this study has demonstrated that opioid substitution treatment provides a wide range of

distinct benefits concerning the reduction of criminality, drug use, social rehabilitation, and

improved health outcomes. However, the study also established that this strategy is yet to be

fully implemented in the United States. This is especially prevalent outside the major cities. The

finding of this study thus suggests the implementation of opioid replacement therapies in

correction facilities to help curb the challenge of dependency and recidivism. This is because the

intervention is better compared to other strategies in ensuring treatment retention and completion

among incarcerated persons and those released from incarceration. However, the limitations in

this study stem from the fact that all of the data were drawn from secondary sources, and some

findings may have become obsolete with time. As such, a study that will rely on primary data

and ensure a true reflection of the events on the field needs to be conducted.

Conclusion

During the analysis process, it is clear that the intervention of opioid replacement therapy is the

most effective prison-based drug and alcohol intervention. This effectiveness stems from the
 14

numerous benefits that accompany this study. When opioid replacement treatment is applied in

the prison setting, it aids in reducing the use of opiates and encourages treatment retention and

completion during and after release from prison. Opioid replacement therapy also reduces

criminal behavior among inmates while limiting engagement in risky behavior such as sharing

syringes. This, in turn, is essential in ensuring that the inmates are shielded from severe illnesses

such as hepatitis C and HIV. With this intervention proving successful, and with the associated

low cost of implementation and association, threes should be a policy to ensure that all

dependent patients in correctional facilities are offered early treatment interventions to help

provide a solution to the challenge.

 15

References

Boksán, K., Dechant, M., Weiss, M., Hellwig, A., & Stemmler, M. (2022). A meta-analysis on

the effects of incarceration-based opioid substitution treatment. Medicine, Science and

the Law. https://doi.org/10.1177/00258024221118971

Brooke, D., Taylor, C., Gunn, J., & Maden, A. (1998). Substance misusers remanded to prison-a

treatment opportunity? Addiction, 93(12), 1851–1856. https://doi.org/10.1046/j.1360-

0443.1998.9312185110.x

Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating Drug Abuse and Addiction

in the Criminal Justice System. JAMA, 301(2), 183.

https://doi.org/10.1001/jama.2008.976

Curtis, M., Larney, S., Higgs, P., Cossar, R. D., Winter, R. J., Stewart, A. C., & Stoové, M.

(2020). Initiation of Medications for Opioid Use Disorder Shortly Before Release From

Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy.

Journal of Addiction Medicine, 15(6), 525–526.

https://doi.org/10.1097/adm.0000000000000788

de Andrade, D., Ritchie, J., Rowlands, M., Mann, E., & Hides, L. (2018). Substance Use and

Recidivism Outcomes for Prison-Based Drug and Alcohol Interventions. Epidemiologic

Reviews, 40(1), 121–133. https://doi.org/10.1093/epirev/mxy004

Drug abusing offenders not getting treatment they need in criminal justice system: Treating

inmates has proven public health, safety and economic benefits. (2009). PsycEXTRA

Dataset. https://doi.org/10.1037/e508822009-001
 16

Farahmand, P., Modesto-Lowe, V., & Chaplin, M. M. (2017, December 1). Prescribing opioid

replacement therapy in U.S. correctional settings. Journal of the American Academy of

Psychiatry and the Law. Retrieved September 26, 2022, from

https://jaapl.org/content/45/4/472

Fazel, S., Bains, P., & Doll, H. (2006). Substance abuse and dependence in prisoners: a

systematic review. Addiction, 101(2), 181–191. https://doi.org/10.1111/j.1360-

0443.2006.01316.x

Friedmann, P. D., Wilson, D., Hoskinson, R., Poshkus, M., & Clarke, J. G. (2018). Initiation of

extended release naltrexone (XR-NTX) for opioid use disorder prior to release from

prison. Journal of Substance Abuse Treatment, 85, 45–48.

https://doi.org/10.1016/j.jsat.2017.04.010

Galassi, A., Mpofu, E., & Athanasou, J. (2015). Therapeutic Community Treatment of an Inmate

Population with Substance Use Disorders: Post-Release Trends in Re-Arrest, Re-

Incarceration, and Drug Misuse Relapse. International Journal of Environmental

Research and Public Health, 12(6), 7059–7072. https://doi.org/10.3390/ijerph120607059

Hamilton, L. K. (2017). The reciprocal lagged effects of substance use and recidivism in a

prisoner reentry context. Health &Amp; Justice, 5(1). https://doi.org/10.1186/s40352-

017-0053-2

Hedrich, D., Alves, P., Farrell, M., Stöver, H., Møller, L., & Mayet, S. (2012). The effectiveness

of opioid maintenance treatment in prison settings: a systematic review. Addiction,

107(3), 501–517. https://doi.org/10.1111/j.1360-0443.2011.03676.x

 17

Knight, K., & Simpson, D. D. (1999). Prison-based substance abuse treatment, residential

aftercare and recidivism. Addiction, 94(6), 833–842. https://doi.org/10.1046/j.1360-

0443.1999.9468337.x

Larney, S., Zador, D., Sindicich, N., & Dolan, K. (2016). A qualitative study of reasons for

seeking and ceasing opioid substitution treatment in prisons in New South Wales,

Australia. Drug and Alcohol Review, 36(3), 305–310. https://doi.org/10.1111/dar.12442

Lyons, T., Womack, V. Y., Cantrell, W. D., & Kenemore, T. (2018). Mindfulness-Based Relapse

Prevention in a Jail Drug Treatment Program. Substance Use &Amp; Misuse, 54(1), 57–

64. https://doi.org/10.1080/10826084.2018.1491054

Miller, A. (2022, February 25). The Role of Social Workers in the Fight Against Drug Abuse.

Work - Chron.com. https://work.chron.com/role-social-workers-fight-against-drug-abuse-

11513.html

Moore, K. E., Roberts, W., Reid, H. H., Smith, K. M., Oberleitner, L. M., & McKee, S. A.

(2019). Effectiveness of medication assisted treatment for opioid use in prison and jail

settings: A meta-analysis and systematic review. Journal of Substance Abuse Treatment,

99, 32–43. https://doi.org/10.1016/j.jsat.2018.12.003

Motamed, M., Marsch, L. A., Solhkhah, R., Bickel, W. K., & Badger, G. J. (2008). Differences

in Treatment Outcomes between Prescription Opioid-Dependent and Heroin-Dependent

Adolescents. Journal of Addiction Medicine, 2(3), 158–164.

https://doi.org/10.1097/adm.0b013e31816b2f84

Pelissier, B. (2007). Treatment Retention in a Prison-based Residential Sex Offender Treatment

Program. Sexual Abuse, 19(4), 333–346. https://doi.org/10.1177/107906320701900401

 18

Peters, R. H. (2006). Review: high rates of substance abuse or dependence in male and female

prisoners. Evidence-Based Mental Health, 9(3), 87–87.

https://doi.org/10.1136/ebmh.9.3.87

Smyth, B. P., Elmusharaf, K., & Cullen, W. (2018). Opioid substitution treatment and heroin

dependent adolescents: reductions in heroin use and treatment retention over twelve

months. BMC Pediatrics, 18(1). https://doi.org/10.1186/s12887-018-1137-4

Soyka, M., Strehle, J., Rehm, J., Bühringer, G., & Wittchen, H. U. (2017). Six-Year Outcome of

Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic

Study in a Nationally Representative Sample. European Addiction Research, 23(2), 97–

105. https://doi.org/10.1159/000468518

Stillwell, G., Jones, H., Shaw, J., Farrell, M., & Marsden, J. (2017). An evaluation of opioid

substitution treatment in prison on risk of mortality in period immediately after prison:

Does leaving prison on OST reduce the risk of death? Drug and Alcohol Dependence,

171, 197–212. https://doi.org/10.1016/j.drugalcdep.2016.08.538

Stöver, H. (2010). Barriers to Opioid Substitution Treatment Access, Entry and Retention: A

Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating

Physicians. European Addiction Research, 17(1), 44–54.

https://doi.org/10.1159/000320576

Treatment Chapter 4. Early intervention, treatment, and management of substance use disorders.

Retrieved September 20, 2022, from

https://addiction.surgeongeneral.gov/sites/default/files/chapter-4-treatment.pdf
 19

Toson, B., Burns, L., & Dolan, K. (2011). Effect of prison-based opioid substitution treatment

and post-release retention in treatment on risk of re-incarceration. Addiction, 107(2),

372–380. https://doi.org/10.1111/j.1360-0443.2011.03618.x

Zarling, P. (2017, November 27). How much of a boost should institutions give low-income

students? Higher Ed Dive. https://www.highereddive.com/news/how-much-of-a-boost-

should-institutions-give-low-income-students/511658/